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A descriptive study of acute outbreaks 
of respiratory disease in Norwegian fattening 
pig herds
Liza Miriam Cohen1* , Carl Andreas Grøntvedt2, Thea B. Klem2, Stine Margrethe Gulliksen3, Birgit Ranheim1, 
Jens Peter Nielsen4, Mette Valheim2 and Camilla Kielland1
Abstract 
Background: Respiratory diseases are major health concerns in the pig production sector worldwide, contributing 
adversely to morbidity and mortality. Over the past years there was a rise in reported incidents of respiratory disease 
in pigs in Norway, despite population wide freedom from Aujeszky´s disease, porcine reproductive and respiratory 
syndrome, porcine respiratory corona virus and enzootic pneumonia. The main objective of this study was to inves-
tigate acute outbreaks of respiratory disease in conventional Norwegian fattening pig herds. The study included 14 
herds. In seven herds with reported outbreaks of acute respiratory disease, data on clinical signs was recorded and 
samples for laboratory examination were collected. Diagnostic protocols were compared by parallel analysis of clini-
cally healthy pigs from seven non-outbreak herds.
Results: The most commonly reported clinical signs were sudden deaths and dyspnea. An average compartment 
morbidity of 60%, mortality of 4% and case fatality of 9% was recorded in the outbreak herds. Post-mortem examina-
tions revealed acute lesions resembling porcine pleuropneumonia in all 28 pigs investigated from the outbreak herds 
and in 2 of the 24 (8%) pigs from the non-outbreak herds. Chronic lesions were recorded in another 2 pigs (8%) from 
the non-outbreak herds. Actinobacillus pleuropneumoniae serovar 8 was isolated from lungs and/or pleura from all 
tested pigs (n = 28) in the outbreak herds, and from 2 out of 24 pigs (8%) in the non-outbreak herds, one pig with an 
acute and another pig with a chronic infection. No other significant bacterial findings were made. Seroconversion to 
A. pleuropneumoniae antibodies was detectable in all outbreak herds analyzed and in six out of seven non-outbreak 
herds, but the risk ratio for seroconversion of individual pigs was higher (risk ratio 2.3 [1.50- 3.43 95% CI; P < 0.001]) in 
the outbreak herds. All herds tested positive for porcine circovirus type 2 and negative for influenza A viruses on oral 
fluid RT-qPCR.
Conclusion: The main etiological pathogen found during acute outbreaks of respiratory disease was A. pleuropneu-
moniae serovar 8. All pigs from outbreak herds had typical lesions of acute porcine pleuropneumonia, and only A. 
pleuropneumoniae serovar 8 was identified. Co-infections were not found to impact disease development.
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Background
Respiratory diseases give rise to major health concerns in 
pig populations worldwide. They are believed to contrib-
ute adversely to morbidity and mortality, increased use of 
antimicrobials, poor pig welfare and reduced productiv-
ity [1–3]. The direct effect of disease on these parameters 
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are however hard to determine in field conditions. Stud-
ies show that coinfections with different respiratory 
agents are common in pigs [4, 5]. Viral infections often 
predispose for secondary bacterial infections. This has 
been studied under experimental conditions, i.e. coinfec-
tions of porcine reproductive and respiratory syndrome 
virus (PRRSV) and Mycoplasma hyopneumoniae [6], 
PRRSV and Actinobacillus pleuropneumoniae [7], swine 
influenza virus (SIV) and Bordetella bronchiseptica [8]. 
Moderate to marked fever, lethargy, coughing, sneezing 
and dyspnea are common clinical signs during disease 
outbreaks [9, 10]. The presence of multiple pathogens 
often increases the severity of disease and occurrence of 
lesions in the respiratory tract [8, 11, 12]. There are dif-
ferences in occurrence and distribution of pathogens 
between countries, regions and herds [13, 14] that con-
tribute to the complexity of respiratory disease.
Due to strict import regulations in Norway, there is 
negligible import of live pigs to the commercial pig popu-
lation [15]. The national yearly yield was approximately 
1.6 million slaughtered pigs in 2018, originating mainly 
from 2580 registered fattener pig herds with a concession 
limit of maximum 2100 slaughtered pigs per year [16, 
17]. The Norwegian pig production is also characterized 
by stringent regulation of antimicrobial drug use and a 
tradition of eradicating diseases from animal populations 
[18, 19]. The commercial pig population in Norway has 
documented freedom from several important respiratory 
pathogens including Aujeszky’s disease virus, PRRSV, 
SIV (apart from influenza A [H1N1]pdm09) [20] and M. 
hyopneumoniae [18]. After the pandemic in 2009/2010, 
antibodies to SIV (H1N1)pdm09 have been detected reg-
ularly from 25 to 50% of examined herds in Norway [21], 
but SIV (H1N1)pdm09 infections in the Norwegian pig 
population has been considered to have limited clinical 
impact [22]. In cases of respiratory disease in Norwegian 
herds, A. pleuropneumoniae has regularly been isolated 
from lungs of carcasses submitted for routine diagnostics 
[23]. Several studies from other countries conclude that 
A. pleuropneumoniae is normally present in most con-
ventional pig herds, having a main reservoir in the tonsils 
of carrier pigs [24, 25]. Accordingly, outbreaks in conven-
tional herds are most often triggered by factors related 
to animal housing, management and environment rather 
than an introduction of the bacteria in a naïve herd [26]. 
Preceding infection with a primary viral pathogen is also 
a possible triggering factor [4]. In the years between 2010 
and 2014 there was an increase in reported acute cases 
of respiratory disease requiring veterinary treatment in 
Norway [27]. A systematic investigation of porcine res-
piratory disease outbreaks in Norway has not recently 
been performed, and updated knowledge is needed for 
appropriate disease prevention and intervention. The 
main objective of this study was to investigate clinical 
outbreaks of acute respiratory disease in Norwegian fat-
tening pig herds, using a group of non-outbreak herds to 
compare diagnostic procedures.
Methods
Study design
Source population
The source population was the conventional fattening pig 
herds located in central and southern parts of Norway in 
the period between September 2017 and October 2018. 
The conventional herds are not part of the Norwegian 
Specific Pathogen Free (SPF) sub-population, in which 
herds are free from e.g. toxin producing Pasteurella mul-
tocida and all serotypes of A. pleuropneumoniae.
Sample population
Seven conventional fattening pig herds with acute out-
breaks of respiratory disease (outbreak herds) and seven 
pig herds without respiratory disease outbreaks (non-
outbreak herds) were included in this study.
The  inclusion  criteria  for outbreak herds  were;  three 
or more pigs displaying acute signs of respiratory dis-
ease  including fever and coughing and/or dyspnea, and/
or otherwise reduced general condition e.g. lethargy 
or inappetence.  Non-outbreak herds  inclusion crite-
ria  were;  absence of acute  clinical signs  of respiratory 
disease  at the time of sampling,  situated in  the same 
geographical area as the outbreak herds.  The non-out-
break herds were not matched to the outbreak herds by 
means of other parameters. Herds were  included only if 
there were more than three weeks until planned slaugh-
ter, due to  follow-up sampling per protocol. Two herds 
were excluded, due to treatment with antimicrobial 
drugs before sampling could be carried out, and insuf-
ficient time from outbreak to planned slaughter, respec-
tively. Descriptive herd data are listed in Table 1.
Recruitment and selection of herds
A network of veterinary practitioners was established 
to collect samples  and herd data.  The  practition-
ers were contacted through emails, letters, meetings and 
announcements in relevant journals and national news-
papers. The veterinarians contacted the project group 
immediately upon being called out to examine pigs with 
symptoms of acute respiratory disease. Outbreak herds 
were recruited for participation by the veterinary practi-
tioners after meeting the inclusion criteria. Non-outbreak 
herds were then recruited by the veterinary practitioners 
contacting herd owners meeting the matching criteria, 
asking their participation and arranging a visit. Com-
plete kits containing materials and detailed instructions 
for sample collection, preservation and transport were 
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pre-distributed to designated pick up points at abattoirs 
and veterinary practice offices and sent to veterinarians 
across the country upon request.
Herd visits
Each outbreak herd was visited on three occa-
sions  (Fig.  1, green boxes); the first visit was conducted 
as soon as possible during the reported  outbreak for 
initial  sampling. The second visit was performed 2 to 5 
days later to conduct interviews and register herd demo-
graphic data. During the third and final visit two to four 
weeks after the first, follow-up samples were collected, 
as described in Fig.  1.  Non-outbreak herds were visited 
on two occasions, once for initial sampling, farmer inter-
views and herd registrations, and secondly for follow up 
sampling.
First visit (outbreak sampling)
Details about the  diagnostic sampling are shown in 
Fig.  1. Diagnostic sampling  in outbreak herds  was per-
formed the day the veterinarian was notified about the 
disease. The veterinary practitioner reported  observed 
clinical signs on a standardized submission form. In these 
herds, three to five pigs were selected for organ collec-
tion, 28 pigs were sampled in total. The selection was 
made from pigs with clinical signs of respiratory disease 
prior to  death or euthanasia by captive bolt and exsan-
guination. Short time from death to sampling was con-
sidered, no additional criteria for sampling were applied. 
In non-outbreak herds three to five pigs  were  haphaz-
ardly selected, 24 pigs were sampled in total. Lungs and 
mediastinum (including pericardium, excluding the 
heart) and trachea caudal to the thoracic inlet were col-
lected. Within each herd, care was given not to sample 
pigs treated with any antimicrobial drugs up to 14  days 
prior to the sampling.
Blood sampling was performed on a total of 10 pigs per 
herd by haphazard selection from as many pens  in the 
compartment  as possible,  up to 10 pens. A total of 141 
pigs were  sampled.  The pigs were selected regardless of 
clinical presentation and restrained by snaring the upper 
jaw. During restraint the pigs were ear-tagged for individ-
ual identification at follow-up sampling during the final 
visit. Rectal temperature was measured, and blood sam-
ples were collected (details in Fig. 1).
Pooled oral fluid (OF) samples were collected from 
two  haphazardly  selected pens (n = 14 pooled OF sam-
ples from 28 pens) using chewing rope as described by 
Prickett et al.   [28]. Care was given to keep the stress of 
the animals during sampling to a minimum.
Second visit (interviews and on‑farm demographic data 
sampling)
Demographic data sampling was obtained by interview-
ing the farmers using a purpose-built questionnaire, see 
details in Fig. 1. Relevant information regarding the dis-
ease outbreaks  including  information about the first 5 
days after noticing the first clinical signs was registered in 
Table 1 Overview of descriptive data in both outbreak and non-outbreak herds (n = 14)
a Herd type: 5 finishers, 2 farrow-to-finish. 6 herds: one compartment affected and tested. 1 herd: two compartments affected and tested, compartment average 
presented
b Herd type: 6 finishers, 1 farrow-to-finish. One compartment tested per herd
c Number of pigs in the herd/at the production site at the time of the outbreak/sampling
d Fattening pigs slaughtered over the last 12 months. Not considering piglets for sale
e Number of pigs the compartment with the ongoing outbreak
f m3 in the compartment divided by the number of pigs
g total  m2 in the compartment divided by the number of pigs, not considering empty stalls, walkways etc
Descriptive herd data Outbreak herds (n = 7)a Non-outbreak herds (n = 7)b
Median Interquartile range Median Interquartile 
range
Production site Single site production
No. of suppliers 2 7 1 0
Herd  sizec 650 310 500 350
Yearly  yieldd 2109 1818 1543 1661
Estimations from on‑farm registrations:
Pigs in  compartmente 155 90 196 255
Compartment volume per  pigf 3.9 m3 2 m3 4.3 m3 1.5 m3
Floor space per  pigg 1.0 m2 0.2 m2 1.1 m2 0.2 m2
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outbreak herds. The following data was registered: dates 
of the pigs’ arrival to compartment, a description of earli-
est observed clinical signs, onset of disease, time to vet-
erinary contact, time from the first clinical signs to the 
initial sampling, numbers of pigs displaying clinical signs, 
applied antibiotic treatment, and number of sick and 
dead pigs from the start of the outbreak until the time of 
the interview.
Final visit (follow up)
During the final visit, second blood samples were col-
lected from individually ear tagged pigs, and rectal tem-
perature measured in the same pigs.
Sample handling and diagnostics
Procedures for sample handling are presented in Fig. 1.
Pathological examination
Organs from 52 pigs were subject to post-mortem exami-
nation. The pericardium, pleura, trachea, bronchi, lung 
parenchyma and tracheobronchial lymph nodes from 28 
to 24 pigs from outbreak herds and non–outbreak herds 
respectively, were examined at the Norwegian Veteri-
nary Institute (NVI) according to a standardized protocol 
(Additional file 1). Tissue samples from the lungs, pleura 
and lymph nodes  were fixed, processed, sectioned  and 
stained for histological examination (Additional file 2). In 
total,  112  histological sections  from the  outbreak herds 
and 36 sections from 3 non-outbreak herds were exam-
ined following a standardized protocol (Additional file 2).
Bacteriology
Sampling (on charcoal transport swabs) for bacterial cul-
tivation was performed during postmortem examination 
of 52 lungs and pleurae, see details in Table 3. The lung 
surface was flamed and  aseptically  incised  before swab-
bing of lung tissue. The swabs were cultivated as a part of 
the routine diagnostics at NVI (Additional file 3).
Serotyping by whole genome sequencing
Serovar identification of cultured A. pleuropneumoniae 
(n = 31 isolates) was performed on sequence data, gener-
ated through whole genome sequencing of the A. pleu-
ropneumoniae isolates at Statens Serum Institut (SSI), 
Copenhagen, Denmark. The serovar was determined 
based on the presence of the serovar specific cps operons 
[29, 30]. Details regarding the method are described in 
Additional file 3.
Serology
The serum samples (n = 282) were analyzed using com-
mercial diagnostic kits for antibodies to A. pleuro-
pneumoniae, influenza A virus, PRRSV, PRCV and 
M. hyopneumoniae. The analyses were performed as 
described by the manufacturers; details are given in 
Additional file  3. Interpretation of the test results were 
categorical, based on the cut-off values recommended 
by the test manufacturers. Presence of antibodies to 
PRRSV, porcine respiratory corona virus (PRCV) and M. 
hyopneumoniae were tested in the second serum sample 
(n = 141). Serum ELISA was conducted on paired serum 
samples (n = 282) from individual pigs for antibodies to 
influenza A virus and A. pleuropneumoniae.
Virology
The presence of  influenza A virus and porcine circo-
virus type 2 (PCV2)  nucleic acids  in pooled oral flu-
ids  (n = 14)  were  analyzed  with  real time polymerase 
chain reaction (PCR)  by  in-house procedures (Addi-
tional file  3). A cycle threshold (Ct)  value  for influenza 
virus  below  37 was  considered  positive.  PCV2  quan-
titative PCR (qPCR) is a quantitative test where results 
are given as measured nucleotide copies in 200 µL sam-
ple, calculated  from repeated measures at  different Ct 
values and results are  reported as low  (< 104  copies), 
moderate (104–107 copies) or high (> 107 copies).
Statistical analyses
Our sample size of 10 serum samples per herd was cho-
sen based on an estimate of at least one positive animal if 
the prevalence of our disease in question is around 25% 
at a 95% confidence level. The same sample size was used 
for agents not present in the population, that we did not 
expect to find, due to practical reasons.
Statistical analyses  of  the  data were performed  using 
the software Stata (STATA SE/15 for Windows; 
Stata Corp., College Station, TX, USA).  Descriptive 
numeric  results are presented as average values and the 
standard deviation (SD) for data with a normal distribu-
tion, or median value followed by the interquartile range 
(iqr) for data that was not normally distributed.
Rectal temperatures from the first  visit and from the 
final visit to the herd were compared. The variable “fever” 
was defined as a rectal temperature above 39.5 °C. Odds 
ratios for fever during the outbreak sampling compared 
to fever during  follow-up visits, were calculated using a 
Stata 15 case–control odds-ratio calculator.
Morbidity was measured as the proportion of pigs with 
clinical signs of respiratory disease of the total number 
of pigs in the herd (herd morbidity) and in the compart-
ment (compartment morbidity). Mortality was measured 
as the proportion of pigs dying during the outbreak, out 
of the total number of pigs in the herd (herd mortality) 
and in the compartment (compartment mortality). Case 
fatality, an indicator of pathogen virulence and disease 
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lethality, was measured as the proportion of pigs that 
died during the outbreak and displayed clinical signs of 
respiratory disease prior to their death, out of the total 
number of pigs displaying respiratory disease.
A herd was classified as seroconverted if at least one 
pig shifted from negative to positive status and no pigs 
shifted from positive to negative status. The proportion 
of seroconverted pigs in each herd was calculated. Sam-
ples from pigs that could not be identified by ear tags 
(one herd, n = 10) were excluded. When calculating the 
incidence proportion and risk ratios for seroconver-
sion to A. pleuropneumoniae, pigs that were seroposi-
tive on the first serum sample were excluded from the 
population at risk. Incidence proportion was defined as 
the proportion of the seronegative pigs that seroconvert 
during the time at risk. Time at risk was defined as time 
between paired serum samples. The risk ratio (RR) for a 
pig to seroconvert in outbreak herds, compared to non-
outbreak herds, was calculated using a Stata15 Cohort 
study risk-ratio calculator the 95% confidence interval 
(CI). The statistical significance of the calculated associa-
tion, whether it was likely that the RR was different from 
1, was indicated by the reported p value.
Results
Clinical findings
Median number of days from the farmers noticed clini-
cal signs of respiratory disease until calling the local 
veterinary practitioner was 1 day.  Onset of outbreak 
was 35 days (median, iqr 43) after the pigs arrived at the 
compartment. The severity of the clinical signs varied 
between outbreak herds. Clinical signs reported by the 
veterinary practitioner were mainly sudden deaths (four 
herds) and dyspnea (three herds). Signs such as fever, 
bloody froth from oronasal openings, cough and lethargy 
were also reported, and it was observed that sick pigs 
were reluctant to chew on the cotton ropes used for OF 
sampling.
In all herds, intramuscularly administrated procaine 
benzylpenicillin was used to treat sick pigs over 3 to 5 
days. In one herd, tiamulin was additionally administered 
in the drinking water for 4 days. Treatments were started 
by the veterinary practitioner during the first visit after 
the outbreak of disease. All herd owners reported the 
treatment to effectively reduce acute clinical signs and 
stop the further spread of disease.
The average compartment morbidity during the out-
break was 60% (SD 43, range 6–100%), while herd mor-
bidity was 25% (SD 19, range 0.9–51%) in the outbreak 
herds. Case fatality rate during the disease outbreaks was 
on average 9% (SD 12, range 0–34%) over 5 days, sug-
gestive of a low virulent agent. During the outbreaks, 
compartment mortality was 4% on average (SD 3, range 
0–10%), while herd mortality was 2% (SD 2, range 0–5%). 
Proportion of pigs in the outbreak herds measuring a rec-
tal temperature above 39.5 °C was 57.6% (n = 54) and 30% 
at the first and final visit, respectively. For the non-out-
break herds the proportion of pigs with a rectal tempera-
ture above 39.5 °C was 42.4% (n = 50) and 10% at first and 
final visit, respectively. The odds for a temperature above 
39.5 °C were higher (odds ratio = 2.8, 95% CI 1.17–6.70), 
during outbreak than during follow-up in the outbreak 
herds. There were no dropouts among the study animals, 
the number of animals tested at the visits was the same. 
Median number of days between first and final visit was 
22  days (iqr 5) in outbreak herds and 18  days (iqr 4) in 
non-outbreak herds.
Diagnostics
Pathological examination
Results from the pathological examinations of 52 organs 
are presented on herd level in Table 2. Gross pathology of 
the lungs was detected in all pigs (n = 28) from the out-
break herds. Acute pleural lesions were reported in 25 of 
these pigs (89%) and chronic pleural lesions, were found 
in one. Typical lesions of acute pneumonia were found 
in all the pigs. The acute lesions were principally dorsally 
distributed in all lung lobes, but the caudal lobes were the 
most affected. Chronic lung lesions were observed in one 
pig. Moderate to severe enlargement of the tracheobron-
chial lymph nodes was a prevalent finding (n = 22, 73%) 
in the pigs with pneumonia. Characteristic gross lung 
lesions are shown in Fig. 2. 
In the non-outbreak herds various gross lung lesions 
were detected in seven of the 24 pigs (29%). Pleuritis 
was observed in two of 24 pigs (8%), where one had an 
acute pleuritis, and the second pig focal chronic pleuri-
tis. Pneumonia was observed in four other pigs. Mild, 
focal, acute lesions were seen in two of them, while 
similar acute lesions and abscess formation was seen 
in another. Multifocal, necrotizing, chronic pneumo-
nia was diagnosed in the fourth pig. A single pig from a 
non-outbreak herd had gross lung lesions of multifocal 
bleeding and mottled grayish green areas indicative of 
larval migration by Ascaris suum. Diagnostic results for 
individual herds, including the gross findings are sum-
marized in Table 2.
Histopathological changes agreed with the acute mac-
roscopic lesions observed. Histological examination 
revealed fibrin and neutrophil deposits on the pleura. 
In the lung parenchyma there was alveolar filling with 
necrotic leukocytes, neutrophils and fibrin. Interstitial 
edema and hemorrhage, peribronchial and peribron-
chiolar leukocyte infiltration was observed. Subacute to 
chronic, necrotic lesions of varying sizes were demar-
cated by macrophages, lymphocytes and plasma cells 
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surrounded by connective tissue. Histopathological path-
ological changes in lymph nodes included neutrophils in 
subcapsular sinuses in cases of acute pneumonia. When 
investigating samples from lungs without gross lesions 
from the non-outbreak herds there was occasional occur-
rence of mononuclear cell infiltrates and fibrin deposits 
Fig. 2 Lungs from pigs that displayed clinical signs of respiratory disease prior to death. Macroscopic lung lesions. a. Acute pleuropneumonia—
Macroscopic lesions include fibrinopurulent pleuritis (dotted ring), edematous lungs with multifocal to coalescing hemorrhagic and hyperemic 
areas (dashed ring). A. pleuropneumoniae was cultured in abundance from pleura, left and right caudal lung lobes. b Chronic pleuritis, acute 
pneumonia. Macroscopic lesions include fibrous pleuritis (dotted ring), and focal, dark red areas of condensed lung tissue (dashed ring). The 
tracheobronchial lymph nodes were moderately enlarged (continuous ring). A. pleuropneumoniae was cultured from the right caudal lung lobe; no 
bacteria were retrieved from the chronic pleuritic lesion
Table 3 Summary of bacteriologic findings on at least one sample from lung and pleura in 28 pigs from outbreak herds 
and 24 pigs from non-outbreak herds
a In total, 28 pleural swabs and 52 lung swabs were collected in outbreak herds, while 24 pleural and 49 lung swabs were collected in non-outbreak herds. The sum of 
findings per lung or pleura are presented here
b From swabs of acute lung lesions. A. pleuropneumoniae was the sole microbial species detected in lung samples from 20 of these pigs
c From swabs of pleuritic lesions. A. pleuropneumoniae was cultured from 26 pleuritic lesions. A. pleuropneumoniae was the sole microbial species detected in pleura 
samples from 13 of these pigs
d From swabs of lung lesions. A. pleuropneumoniae was the sole microbial species detected in one lung with chronic lesions, while the other was a mixed culture from 
an acute lesion
Microbial species Outbreak  herdsa Non-outbreak  herdsa
Lung
n = 28
Pleura
n = 28
Lung
n = 24
Pleura
n = 24
Actinobacillus pleuropneumoniae 28b 26c 2d 0
Pasteurella multocida 1 3 – –
Streptococcus spp. 5 10 – –
Haemophilus parasuis – – – –
Bordetella bronchiseptica – – 1 –
Coliform bacteria 2 2 – –
Other: Actinomyces hyovaginalis, Trueperella pyogenes, Proteus 
mirabilis, Fusobacterium spp.
3 – 1 –
Unspecific mixed culture – 1 4 1
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on the pleura or in alveolar lumen, and areas of intersti-
tial bleeding.
Bacteriology
Actinobacillus pleuropneumoniae was cultured from 
all sampled pigs (n = 28) from outbreak herds (n = 7). 
Abundant growth of A. pleuropneumoniae was present 
in lung tissue in all 28 pigs and on pleura in 26 pigs. In 
samples from 20 of the lungs and 13 pleurae, A. pleuro-
pneumoniae was the sole microbial species detected. In 
the remaining samples, a range of bacteria were detected 
in addition to A. pleuropneumoniae and the results are 
shown in Table  3. Swabs from non-outbreak pigs’ lungs 
produced mostly negative bacteriology. From non-out-
break herds, A. pleuropneumoniae was isolated from 
lung parenchyma in two out of 24 pigs. The A. pleuro-
pneumoniae isolates originated mainly from areas with 
acute gross pathology (Table 2). In one non-outbreak pig 
A. pleuropneumoniae was cultured from a chronic lung 
lesion.
Serotyping of A. pleuropneumoniae on genome level 
revealed that all sampled isolates belonged to serovar 8.
Serology
The 282 serum samples were successfully analyzed in 
one session. Antibodies to A. pleuropneumoniae were 
detected in samples from six (86%) outbreak herds and 
four (57%) non outbreak herds. At the first serum sam-
ple, 35% (25 of 71) of the pigs in the outbreak herds were 
seropositive, and 37% (26 of 70) in the non-outbreak 
herds. At the second serum sample, 89% (63 of 71) and 
60% (42 of 70) of the pigs were positive in the outbreak 
and non-outbreak herds respectively, details are listed in 
Table 2. Six outbreak herds and six non-outbreak herds 
were considered seroconverted, indicative of an active 
infection in the period from the first to the second visit. 
Seroconversion in the seventh outbreak herd could not 
be assessed due to missing ear tags. Proportion of sero-
converted pigs in each outbreak herd ranged from 30 to 
100%, and from 0 to 80% in non-outbreak herds (Table 2). 
Incidence proportion was 0.96 (SD 0.10) in outbreak 
herds over the median time at risk of 22 days. Incidence 
proportion in the non-outbreak herds was 0.44 (SD 0.36) 
over the median time at risk of 18  days. The risk for 
seroconversion was more than double compared to pigs 
from non-outbreak herds (RR 2.3 [1.50–3.43 95% CI; 
P < 0.001]).
Antibodies to influenza A virus were detected in one 
outbreak herd, where one pig seroconverted during 
the sampling period, and two pigs were found to have a 
reduced antibody titer to below cutoff. Influenza A-anti-
bodies were not detected in the remaining six outbreak 
herds or the non-outbreak herds. The proportion of SIV 
seropositive herds was 7% out of the herds combined. 
Antibodies to M. hyopneumoniae, PRCV and PRRSV 
were not detected in samples from any herds.
Virology
The 14 pooled OF samples from 28 pens, median num-
ber of pigs per pen was 10 (range 5–19), were all negative 
for Influenza A Viruses. Quantification of PCV2 by RT-
qPCR turned out low or moderate in all samples, results 
per herd are shown in Table 2.
Discussion
Field outbreaks of acute respiratory disease in Norwegian 
fattening pigs were investigated and A. pleuropneumo-
niae serovar 8 was the main pathogen detected, with neg-
ligible presence of co-infections. Clinical signs reported 
were in agreement with previous reports of A. pleuro-
pneumoniae infections, which are described to have a 
diverse clinical presentation [31]. Even with the large var-
iation in morbidity and mortality rates, the results from 
this study were in line with observations from other stud-
ies, as research on outbreak characteristics of respiratory 
disease show that morbidity can range from 10 to 100% 
[26]. Mortality during outbreaks of acute porcine pleuro-
pneumonia is usually reported to be between 1 and 10% 
[26]. Case fatality rates are not commonly included in this 
research literature but is a more precise measure of the 
lethality of a disease, especially if little information about 
other illnesses is available. Disease that affects mortality 
are likely to have common risk factors [32] and the use of 
case fatality rate is a more robust measurement and less 
subjected to confounders such as that of other illnesses.
Even as a single infectious primary agent, A. pleu-
ropneumoniae can cause severe clinical signs. During 
acute porcine pleuropneumonia, high fever is common 
[33, 34]. For pigs in the age range from 3 to 6  months, 
body temperatures normally span from 38.5 to 39.3  °C 
[35], and the proportion of pigs displaying a fever can be 
indicative of an outbreak. In the present study, the pigs 
were restrained by snaring the upper jaw during clinical 
examination and blood collection, which is stressful for 
the animal [36]. The cutoff for fever at 39.3 °C + 0.2 was 
used in the study to compensate for this stress. Higher 
odds for displaying fever in the herds during outbreak 
than at the final visit were found among the pigs in this 
study. This signified body temperature as a disease char-
acteristic during outbreaks of porcine pleuropneumonia, 
although technical biases like personnel and thermom-
eters used might have influenced our results. This coin-
cided with results from a recent study from Finland [37].
There are 18 acknowledged A. pleuropneumoniae sero-
vars, of which some were recently described [38]. From 
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the Norwegian pig population, serovars 2, 6, 7, 8 and 
10 have previously been reported [39]. Serovar 8 has 
been most commonly associated with clinical disease 
in recent years, followed by type 6 [40]. However, these 
previous findings were all based on antibody agglutina-
tion tests which are prone to cross-reactions, for instance 
between serovars 3, 6, 8 and 15 [41]. All A. pleuropneu-
moniae strains in this study belonged to type 8, raising 
questions about the importance of serovar 6. Underes-
timation of serovar 8 has occurred in Canada [42], Eng-
land and Wales [43]. Serovar 8 is typically viewed as low 
virulent and is less often associated with clinical disease 
globally. In a study describing clinical presentation of 
different serovars in experimentally infected pigs [33], 
serovars that were less commonly associated with disease 
were able to produce severe clinical signs, including high 
fever. This could perhaps be a result of absence of other 
respiratory agents including more virulent serovars of A. 
pleuropneumoniae.
The macro- and histopathologic findings were typical 
for acute pleuropneumonia caused by A. pleuropneu-
moniae [44–46], supporting that A. pleuropneumoniae 
was the main etiologic pathogen in these outbreaks. 
Direct agent detection, primarily by bacteriological cul-
turing in affected lung tissue obtained during necropsy, 
is considered the most adequate method for diagnosing 
porcine pleuropneumonia [31]. Direct PCR is a method 
that would be expected to yield similar results but would 
not allow for storing of the bacterial isolates for further 
molecular testing, as was done in this study. We observed 
a low incidence of pathological lesions in non-outbreak 
herds, and A. pleuropneumoniae was only isolated from 
lesions resembling porcine pleuropneumonia. Other 
bacteria, including P. multocida and Streptococcus spp., 
were also detected in a few samples in this study. Both 
are known opportunistic bacteria that colonize the upper 
respiratory tract of healthy pigs [4]. Streptococcus suis 
is the most important streptococcal swine pathogen 
found to contribute to bronchopneumonia [47]. It is not 
unlikely that the bacteria could colonize areas already 
infected with A. pleuropneumoniae. The lesions might 
then be hard to distinguish from the primary pathogen, 
particularly if large parts of the lungs are affected. In one 
outbreak herd all five lungs had growth of other bacteria. 
They could have been contaminated during collection, 
transport or sampling. Alternatively, these pigs were all 
colonized by secondary bacterial pathogens. The number 
of herds included in this study was too low to investi-
gate whether the presence of these bacteria was linked to 
any differences in outbreak characteristics or diagnostic 
results. The low occurrence of common secondary invad-
ers could have been explained by the short time span 
between registered disease and sampling. It has been 
questioned whether the actions that led to the eradica-
tion of M. hyopneumoniae from the Norwegian pig pop-
ulation [18] also significantly reduced the occurrence of 
other pathogens. This has not yet been investigated.
Treatment with procaine benzylpenicillin was in line 
with the therapeutic guidelines published by the Norwe-
gian Medicines Agency as the drug of choice for acute 
porcine pleuropneumonia [48]. Similar recommenda-
tions have been published in Finland and Sweden [49, 
50]. In Denmark, tilmicosin and tulathromycin have 
been commonly used against acute pleuropneumonia 
[51] partly due to the convenience of peroral adminis-
tration, not due to reduced susceptibility to benzylpeni-
cillin. National surveillance programs for antimicrobial 
resistance in these countries have recently reported a 
high proportion of A. pleuropneumoniae isolates being 
susceptible to benzylpenicillin [51–53]. Nevertheless, 
there are no recently published studies on the efficacy of 
procaine benzylpenicillin for porcine pleuropneumonia 
in Norway. Such knowledge of causative pathogens is the 
fundament for correct and prudent use of antimicrobi-
als. The details to antimicrobial resistance patterns of A. 
pleuropneumoniae in Norway are currently being studied 
further.
Seroconversion to A. pleuropneumoniae had occurred 
in most of the herds, in many cases in absence of clini-
cal disease. The risk for seroconversion to A. pleuropneu-
moniae for pigs in outbreak herds was more than double 
compared to pigs from non-outbreak herds, despite small 
within-herd populations at risk due to many seropositive 
pigs in the first serum samples. Seroconversion to less 
virulent strains might have happened without resulting 
in a cross-protection to the outbreak-causing serovar. 
In Finland, Haimi-Hakala et  al. observed no difference 
in either prevalence of seroconverted herds or propor-
tion of seroconverted pigs per herd in the outbreak case 
group and non-outbreak control group [37]. They dis-
cuss that neither single or paired serum sampling for the 
diagnosis of acute respiratory disease in field conditions 
is of much value due to both a lack of details concerning 
the initiation time of infection and a high prevalence of 
subclinical infections with A. pleuropneumoniae. The risk 
for seroconversion was not addressed in their paper. A 
Danish study from 2004 investigated correlations in sero-
conversion to A. pleuropneumoniae and concluded that 
variation in seroconversion was mainly explained by a 
common batch level factor, that varies between farms and 
batches within a farm [54]. Outbreaks of disease might 
be viewed as a batch level factor in this sense. In cases 
of all-in-all-out rearing by compartment, which is com-
mon, batches of pigs are usually housed separately. As 
we observed, the outbreaks were often restricted to sin-
gle compartments. Risk factors can be related to animal 
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housing, management and environment [26], and infec-
tion pressure might be increased during clinical disease 
and is a likely trigger for seroconversion. Risk factor anal-
yses were beyond the scope of this paper due to a lower 
number of herds in our study than what was expected. 
The seeming decrease in outbreak occurrence might have 
resulted from of a collective effort in the Norwegian pig 
production system to increase the health status of herds 
with reoccurring problems with respiratory disease prior 
to our sampling.
When investigating SIV antibody titers we found that 
only one outbreak herd was seropositive. Even though 
one pig seroconverted during the sampling period, two 
pigs were found to have reduced antibody titer. Since 
a single false-positive serological reactor could not be 
excluded, the true status of these animals was uncertain. 
There being multiple false-positive reactions in one herd, 
which would have been the case here, was perhaps less 
likely. The proportion of seropositive herds in this study 
was less than what is found on a national level, where 
approximately 25% of the herds are reported positive 
[21]. The virology results from our study suggested that 
neither SIV nor PCV2 contributed to the disease out-
breaks in the study population. The absence of SIV in all 
OF samples supported the lack of pathological lesions 
and serological results indicative of SIV infection. No 
difference was detected in PCV2 levels between the out-
break- and the non-outbreak herds. Reluctancy of sick 
pigs to chew on the ropes could have resulted in unrep-
resentative PCV2 levels. Since PCV2 levels was tested on 
pooled samples we have no information on the individual 
pig’s contribution to the sample.
The health status of the Norwegian pig population is 
very good and have many similarities to the one of Fin-
land in the sense that they are free from M. hyopneumo-
niae, PRRSV and until recently PRCV [21]. In Finland, a 
more diverse outbreak etiology has been observed [37]. 
In the Finnish study, A. pleuropneumoniae was found to 
be the most likely cause of disease in 14 of the 20 sampled 
herds. In most of these herds, A. pleuropneumoniae was 
the only etiologic pathogen identified. Similarly, 16 out-
breaks of respiratory disease were studied in the Nether-
lands [10] concluding that five of these were most likely 
caused by A. pleuropneumoniae, while seven were caused 
by SIV (H1N1) and (H3N2). Like in our study, they did 
not find any clear evidence of specific dual infections.
Conclusion
The main etiological pathogen of acute outbreaks of res-
piratory disease in the included Norwegian fattening pigs 
was A. pleuropneumoniae. All pigs from outbreak herds 
were found to have typical lesions of acute porcine pleu-
ropneumonia, and only A. pleuropneumoniae serovar 8 
was identified. The clinical presentation and pathology of 
A. pleuropneumoniae was in line with previous reports 
on field outbreaks internationally. Co-infections did not 
seem to be of impact on disease development.
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